Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results
Quarterly EsoGuard® test volume increased 10 percent Strengthened balance sheet following completion of $29.8 million Series B Preferred Stock Offering...
Month: May 2024
Palo Alto Networks and Accenture Team to Secure the GenAI Transformation Journey
New offerings powered by Precision AI™ by Palo Alto Networks help organizations accelerate AI adoption securely NEW YORK and SANTA...
Sanofi obtains Exclusive Commercialization Rights for losmapimod outside of the U.S. from Fulcrum Therapeutics
DENVER, Colo., May 13, 2024 (247marketnews.com)- Fulcrum Therapeutics, Inc. (Nasdaq:FULC) entered into a collaboration and license agreement with Sanofi (Nasdaq:SNY) for...
Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results
Quarterly EsoGuard® test volume increased 10 percent Strengthened balance sheet following completion of $29.8 million Series B Preferred Stock Offering...
Icahn Enterprises L.P. Intends to Offer New Senior Notes
SUNNY ISLES BEACH, Fla., May 13, 2024 /PRNewswire/ -- Icahn Enterprises L.P. (NASDAQ: IEP) – Icahn Enterprises L.P. ("Icahn Enterprises")...
Ensysce Biosciences Reports First Quarter 2024 Financial Results
PF614's Phase 3 Clinical Plans Affirm the Path to Regulatory Approval FDA Breakthrough Therapy Designation of PF614-MPAR Expedites Clinical Program...
Cheetah Net Supply Chain Service Inc. Announces 1st Quarter 2024 Results and Provides Corporate Update
CHARLOTTE, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- Cheetah Net Supply Chain Service Inc. (“Cheetah” or the “Company”) (Nasdaq CM:...
CSW Industrials Announces Date for Fiscal Fourth Quarter and Full Year 2024 Earnings Release Conference Call
DALLAS, May 13, 2024 (GLOBE NEWSWIRE) -- CSW Industrials, Inc. (NASDAQ: CSWI) announced that it will release its earnings results...
Noventiq Launches New Solution: uDMS, the Next-Generation AWS Cloud-Based Document Management System
This cloud-hosted solution significantly reduces IT overheads and enhances scalability and cost-effectiveness Contacts Investors: Steven Salter VP Corporate Affairs IR@noventiq.com...
Noventiq Launches New Solution: uDMS, the Next-Generation AWS Cloud-Based Document Management System
This cloud-hosted solution significantly reduces IT overheads and enhances scalability and cost-effectiveness Contacts Investors: Steven Salter VP Corporate Affairs IR@noventiq.com...
Noventiq Launches New Solution: uDMS, the Next-Generation AWS Cloud-Based Document Management System
This cloud-hosted solution significantly reduces IT overheads and enhances scalability and cost-effectiveness Contacts Investors: Steven Salter VP Corporate Affairs IR@noventiq.com...
Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
SOLANA BEACH, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling...
Expert Panel Review Further Validates Use of ZORYVE® (roflumilast) Topical Foam, 0.3% for Treatment of Seborrheic Dermatitis Across Diverse Hair Types Published in Journal of Clinical and Aesthetic Dermatology
WESTLAKE VILLAGE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing...
Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones
Multiple Value-creating Catalysts Across the Annexon Portfolio Throughout 2024Pivotal Phase 3 Data for ANX005 in Guillain-Barré Syndrome (GBS) Expected in...
Zebra Study: 84% of U.S. and UK Hospital Leaders Prioritize Digitizing Inventory Management Solutions
Findings underscore the need for hospitals to ensure real-time availability of medical assets for optimal patient care Contacts Media Contact:...
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
CARLSBAD, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today...
X4 Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
BOSTON, May 13, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people...
UroGen Pharma Announces Date for ENVISION Data, New Long-Term Jelmyto Durability Data, and Reports 2024 First Quarter Financial Results and Business Highlights
12-month duration of response data from ENVISION study of UGN-102 to be discussed during company sponsored virtual event on June...
Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
No limit to number of fragments included in the pools Optimized chemistry enables direct synthesis of up to 500 bp...
Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates
Interim data from initial dose escalation cohorts from Phase 1 CARDINAL trial of TERN-701 (allosteric BCR-ABL) in CML expected in...
Steakholder Foods Signs Commercial Cooperation agreement with Wyler Farm
Collaboration will Transition the Company from R&D to Commercialization REHOVOT, Israel, May 13, 2024 /PRNewswire/ -- Steakholder Foods Ltd. (Nasdaq:...
SunCar Technology Group Inc. Broadens Intelligent Insurance Services through Enhanced Partnership with Xiaomi Group’s Insurance Affiliate
NEW YORK, May 13, 2024 /PRNewswire/ -- SunCar Technology Group Inc. (the "Company" or "SunCar") (NASDAQ: SDA), an innovative leader...
Reviva to Present New Preclinical Efficacy Data on Brilaroxazine in Idiopathic Pulmonary Fibrosis at 2024 ATS International Conference
CUPERTINO, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage...
Redfin Reports Demand For Vacation-Home Mortgages Fell 40% in 2023 As Housing Costs Rose to Record High
Austin and the Bay Area saw the biggest declines in mortgages for second homes in 2023. Many of the people...
Rand Capital Reports 12% Increase in Total Investment Income for First Quarter 2024
Strategy focused on expanding portfolio composition with new debt investments drives total investment income growth of 12% to $2.1 million...
Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
CAMBRIDGE, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a...
Ontrak Health Announces New Health Plan Customer Providing Behavioral Healthcare Solutions
Community Care Plan to leverage Ontrak Health and its Advanced Engagement System for the Plan’s adult Medicaid population Contacts Company...
Nano Dimension Announces Q1/2024 Conference Call to Discuss Quarterly Results
Participants Are Welcome to Listen June 3rd at 9:00 am ET Waltham, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Nano...
NICE Announces Interactions 2024, Shaping the New Generation of CX AI Excellence and Welcomes Nicole Kidman as Celebrity Keynote
Interactions 2024 brings together top CX thought leaders to showcase the latest groundbreaking innovations for cloud, digital and AI transformations...
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
The collaborative center will help to lower barriers to RNA innovation and discovery Contacts Media Contact: Liz Robinson of CG...
Petosemtamab granted Breakthrough Therapy Designation by the U.S. FDA
UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company...
Avaya and LivePerson Announce New Partnership to Deliver Best-in-Class CX
CX leaders to integrate product, go-to-market, and services to provide a unified, omnichannel suite with faster time-to-value and accelerated, derisked...
Jasper Therapeutics Announces Briquilimab Development Program in Asthma
REDWOOD CITY, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company...
Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference
WATERTOWN, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery,...
IMUNON Reports First Quarter 2024 Financial Results and Provides Business Update
Conference Call Begins Today at 11:00 a.m. Eastern TimeLAWRENCEVILLE, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN),...
Ferroglobe PLC Schedules First Quarter 2024 Earnings Call for May 15, 2024
LONDON, May 13, 2024 (GLOBE NEWSWIRE) -- Ferroglobe PLC (NASDAQ: GSM) announced today that it will issue first-quarter financial results...
GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
Interim data readout of Phase 2a biomarker study evaluating lead program GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (IPF)...
AC Immune and Takeda Sign Exclusive Option and License Agreement Valued up to $2.1B
DENVER, Colo., May 13, 2024 (247marketnews.com)- Takeda (NYSE:TAK) and AC Immune SA (NASDAQ:ACIU) formed an exclusive, worldwide option and license...
Cepton Announces Significant Engineering Contract with Koito
Key development contract to jump-start execution of new OEM program Contacts Cepton, Inc. Investors: InvestorRelations@cepton.com Media: Faithy Li, media@cepton.com Koito...
Collegium Announces $35 Million Accelerated Share Repurchase Program
STOUGHTON, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed...